Search

Your search keyword '"Koschmieder, Steffen"' showing total 19 results

Search Constraints

Start Over You searched for: Author "Koschmieder, Steffen" Remove constraint Author: "Koschmieder, Steffen" Journal leukemia Remove constraint Journal: leukemia
19 results on '"Koschmieder, Steffen"'

Search Results

4. Mast cell deficiency prevents BCR::ABL1 induced splenomegaly and cytokine elevation in a CML mouse model

5. Clinicohematologic and molecular response of essential thrombocythemia patients treated with pegylated interferon-α: a multi-center study of the German Study Group-Myeloproliferative Neoplasms (GSG-MPN)

6. Second versus first wave of COVID-19 in patients with MPN

7. Direct oral anticoagulants for myeloproliferative neoplasms: results from an international study on 442 patients

8. High mortality rate in COVID-19 patients with myeloproliferative neoplasms after abrupt withdrawal of ruxolitinib

10. Frequency of infections in 948 MPN patients: a prospective multicenter patient-reported pilot study

13. JAK2V617F but not CALR mutations confer increased molecular responses to interferon-α via JAK1/STAT1 activation

15. Recurrent somatic mutations are rare in patients with cryptic dyskeratosis congenita

16. Philadelphia chromosome-negative classical myeloproliferative neoplasms: revised management recommendations from European LeukemiaNet

17. Correction: Frequency of infections in 948 MPN patients: a prospective multicenter patient-reported pilot study

18. Hypoxia-inducible factor 1 (HIF-1) is a new therapeutic target in JAK2V617F-positive myeloproliferative neoplasms

19. JAK2V617F but not CALR mutations confer increased molecular responses to interferon-α via JAK1/STAT1 activation

Catalog

Books, media, physical & digital resources